APA (7th ed.) Citation

Barton, P., Jobanputra, P., Wilson, J., Bryan, S., & Burls, A. (2004). The use of modelling to evaluate new drugs for patients with a chronic condition: The case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction.

Chicago Style (17th ed.) Citation

Barton, P., P. Jobanputra, J. Wilson, S. Bryan, and A. Burls. The Use of Modelling to Evaluate New Drugs for Patients with a Chronic Condition: The Case of Antibodies Against Tumour Necrosis Factor in Rheumatoid Arthritis - Introduction. 2004.

MLA (9th ed.) Citation

Barton, P., et al. The Use of Modelling to Evaluate New Drugs for Patients with a Chronic Condition: The Case of Antibodies Against Tumour Necrosis Factor in Rheumatoid Arthritis - Introduction. 2004.